. Author manuscript; available in PMC: 2022 May 24.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Apr 26;19(7):e400–e405. doi: 10.1016/j.clml.2019.04.007

Table 2.

Multivariate Analysis

	Event/Total	1-Year Relapse (95% CI)	HR (95% CI)^*	P-value^*	HR (95% CI)^†	P-value^†
IDH1/2				0.033		0.046
Control	11/76	0.131 (0.055–0.242)	Reference		Reference
Mutation	6/23	0.288 (0.096–0.516)	2.77 (1.04–7.32)		2.78 (1.02–7.60)

Based on Gray test in univariate analysis

^†

Based on Fine and Gray model adjusted for disease status in multivariable analysis